- Home
- Companies
- Qynapse
- Applications
- Software Solution for Pharma - Medical ...
Software Solution for Pharma - Medical / Health Care - Pharmaceuticals
See clearly and quickly with Qynapse’s AI-powered neuroimaging software platform. Our quest is to enhance your clinical trial design and increase the likelihood of trial success by leveraging our precise and objective AI-powered neuroimaging software platform.
For clinical researchers, pharma and biotech, our neuroimaging software platform QyScore® and our predictive research-use-only platform QyPredict®, has the potential to dramatically increase the likelihood of a successful clinical trial by enhancing trial design, providing measurement precision, simplifying and decentralizing the clinical trial process to improve patient selection and endpoint protection.
- Improve pre-identification of patients by analyzing thousands of imaging datasets simultaneously and in conjunction with other clinical markers
- Automate image pre-processing, quality control and image analysis with results you can trust
- Provide more objectivity and automation to create the potential for more precise measurement of drug efficacy and safety for clinical trials
The future of neuroimaging is here.
Qynapse combines global scientific expertise and proprietary AI with a normative dataset to provide precise and reliable imaging measures, such as:
- Whole brain, white matter and grey matter by lobe
- White matter abnormalities and brain substructures
- Diffusion and functional MRI
- Basal ganglia and thalamus
- Cerebellum, ventricles, brain stem and spinal cord volumes
- Amyloid PET and functional MRI
That’s why Qynapse has global support from the most renowned and respected CNS disease experts and principal investigators.
